Pembrolizumab in Recurrent or Metastatic Medullary Thyroid Cancer
Clinical trial NCT03072160 · COMPLETED
Trial details
- NCT number
- NCT03072160
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-16
- Primary completion
- 2019-11-22
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.